Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.1002/uog.23635 | |
| https://doi.org/10.1002/cam4.3605 | Perspectives, fears and expectations of patients with gynaecological cancers during the COVID‐19 pandemic: A Pan‐European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe) |
| https://doi.org/10.3390/metabo9120302 | Blood Metabolites Associate with Prognosis in Endometrial Cancer |
| https://doi.org/10.1136/ijgc-2019-000567 | Perceptions, expectations, and experiences of gynecological cancer patients: a pan-European ESGO-ENGAGe survey |
| https://doi.org/10.1177/03008916241303022 | European Cancer Organisation Essential Requirements for Quality Cancer Care for ovarian cancer: Focus on the multidisciplinary team |
| https://doi.org/10.1136/ijgc-2019-001070 | Results of the interprofessional and interdisciplinary Berlin round table on patient-reported outcomes, quality of life, and treatment expectations of patients with gynecological cancer under maintenance treatment |
| https://doi.org/10.1136/ijgc-2021-003013 | Response to: Correspondence on "ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors" by Thomassin-Nagarra et al |
| https://doi.org/10.2139/ssrn.4082917 | Survival Prognostic and Surrogate Values of the Early Modeled Ca-125 Kelim Score in First-Line Treatment of Ovarian Cancer: Results from The Gcig Individual Patient Data Meta-Analysis |
| https://doi.org/10.2139/ssrn.4823358 | Nsgo-Ov-Umb1/Engot-Ov30: A Phase Ii Study of Durvalumab in Combination with the Anti-Cd73 Monoclonal Antibody Oleclumab in Patients with Relapsed Ovarian Cancer |
| https://doi.org/10.1016/j.esmoop.2025.105177 | 48P Patient centric approach: The first involvement of patient advocacy within ESGO-ESTO-ESP guidelines for the management of patients with endometrial carcinoma |